Oner S. S., Blumer J. B., Lanier S. M.. Group II Activators of G-protein Signaling: Monitoring the Interaction of Galpha with the G-protein Regulatory Motif in the Intact Cell. Methods in Enzymology 2013; 522 ():153-67. doi:
10.1016/b978-0-12-407865-9.00009-1
Oner S. S., Blumer J. B., Lanier S. M.. Group II activators of G-protein signaling: monitoring the interaction of G-alpha with the G-protein regulatory motif in the intact cell. Methods in Enzymology 2013; 522 ():153-67. doi:
10.1016/b978-0-12-407865-9.00009-1
Oner S. S., Maher E. M., Gabay M., Tall G. G., Blumer J. B., Lanier S. M.. Regulation of the G-protein Regulatory-G alpha(i) Signaling Complex by Nonreceptor Guanine Nucleotide Exchange Factors. Journal of Biological Chemistry 2013; 288 (5):3003-3015. doi:
10.1074/jbc.M112.418467
Oner S. S., Vural A., Lanier S. M.. Translocation of activator of G-protein signaling 3 to the Golgi apparatus in response to receptor activation and its effect on the trans-Golgi network. J Biol Chem 2013; 288 (33):24091-103. doi:
10.1074/jbc.M112.444505
Oner S. S., Vural A., Lanier S. M.. Translocation of Activator of G-protein Signaling 3 to the Golgi Apparatus in Response to Receptor Activation and Its Effect on the trans-Golgi Network. Journal of Biological Chemistry 2013; 288 (33):24091-24103.
Oner Sukru Sadik, Blumer Joe B., Lanier Stephen M.. Group II activators of G-protein signaling: monitoring the interaction of Gα with the G-protein regulatory motif in the intact cell. Methods in Enzymology 2013; 522 (G Protein Coupled Receptors):153-167. doi:
10.1016/b978-0-12-407865-9.00009-1
Ooi M. B., Muraskin J., Zou X. W., Thomas W. J., Krueger S., Aksoy M., Bammer R., Brown T. R.. Combined prospective and retrospective correction to reduce motion-induced image misalignment and geometric distortions in EPI. Magnetic Resonance in Medicine 2013; 69 (3):803-811. doi:
10.1002/mrm.24285
op de Haar M. H., Smith S. A. O., Newton J., Gregoski M.. Community Based Physical Activity Program: Follow up with Past Participants. Medicine and science in sports and exercise 2013; 45 (5):340-340.
Orandi B. J., Van Arendonk K. J., James N. T., Montgomery J. R., Wickliffe C., Kraus E. S., Racusen L. C., Montgomery R. A., Segev D. L.. Early Antibody-Mediated Rejection Portends Worse Long-Term Renal Allograft and Patient Survival. American Journal of Transplantation 2013; 13 ():68-69.
Ornstein S. M., Jenkins R. G., Litvin C. B., Wessell A. M., Nietert P. J.. Preventive services delivery in patients with chronic illnesses: parallel opportunities rather than competing obligations. Ann Fam Med 2013; 11 (4):344-9. doi:
10.1370/afm.1502
Ornstein S. M., Miller P. M., Wessell A. M., Jenkins R. G., Nemeth L. S., Nietert P. J.. Integration and Sustainability of Alcohol Screening, Brief Intervention, and Pharmacotherapy in Primary Care Settings. Journal of Studies on Alcohol and Drugs 2013; 74 (4):598-604.
Ornstein S. M., Nietert P. J., Jenkins R. G., Litvin C. B.. The prevalence of chronic diseases and multimorbidity in primary care practice: A PPRNet report. Journal of the American Board of Family Medicine 2013; 26 (5):518-524. doi:
10.3122/jabfm.2013.05.130012
Orr Gandy K. A., Adada M., Canals D., Carroll B., Roddy P., Hannun Y. A., Obeid L. M.. Epidermal growth factor-induced cellular invasion requires sphingosine-1-phosphate/sphingosine-1-phosphate 2 receptor-mediated ezrin activation. FASEB Journal 2013; 27 (8):3155-66. doi:
10.1096/fj.13-228460
Orr Gandy K. Alexa, Obeid Lina M.. Targeting the sphingosine kinase/sphingosine 1-phosphate pathway in disease: Review of sphingosine kinase inhibitors. Biochim. Biophys. Acta, Mol. Cell Biol. Lipids 2013; 1831 (1):157-166. doi:
10.1016/j.bbalip.2012.07.002
Osguthorpe J. D.. Pathophysiology of and potential new therapies for allergic rhinitis. Int Forum Allergy Rhinol 2013; 3 (5):384-92. doi:
10.1002/alr.21120
Otillio J. K., Tuuri R., Watson T., Titus M. O.. Massive Hemoptysis in a Post-Fontan Procedure Patient. Pediatric Emergency Care 2013; 29 (2):212-214. doi:
10.1097/PEC.0b013e318280d564
Ovbiagele B.. Stroke Management and Recovery. London, UK: Future Science; 2013. doi:
10.2217/9781780841830
Ovbiagele B.. Foreword: Stroke management and recovery. In: Ovbiagele B., editor. Stroke Management and Recovery. London, UK: Future Science, 2013. p. 3-5. doi:
10.2217/EBO.12.489
Ovbiagele B., Bath P. M., Cotton D., Sha N., Diener H. C.. Low glomerular filtration rate, recurrent stroke risk, and effect of Renin-Angiotensin system modulation. Stroke 2013; 44 (11):3223-5. doi:
10.1161/strokeaha.113.002463
Ovbiagele B., Ernstrom K., Markovic D., Raman R.. Trends in antihypertensive drug prescription patterns among ambulatory stroke patients in the United States, 2000-2009. Journal of Stroke and Cerebrovascular Diseases 2013; 22 (8):e568-e575.
Ovbiagele B., Wing J. J., Menon R. S., Burgess R. E., Gibbons M. C., Sobotka I., German L., Shara N. M., Fernandez S., Jayam-Trouth A., Edwards D. F., Kidwell C. S.. Association of Chronic Kidney Disease With Cerebral Microbleeds in Patients With Primary Intracerebral Hemorrhage. Stroke 2013; 44 (9):2409-2413. doi:
10.1161/strokeaha.113.001958
Overstreet A., Tetreault D., Bradford N., McGough J., Thomas R., Moran W., Mauldin P.. Incremental Benefit of Screening for Depression in Geriatric Patients. Journal of the American Geriatrics Society 2013; 61 ():S192-S193.
Overton L. J., Fritsch V. A., Lentsch E. J.. Squamous cell carcinoma of the uvula: An analysis of factors affecting survival. Laryngoscope 2013; 123 (4):898-903. doi:
10.1002/lary.23648
Oyer S. L., Nagel W., Mulligan J. K.. Differential expression of adhesion molecules by sinonasal fibroblasts among control and chronic rhinosinusitis patients. Am J Rhinol Allergy 2013; 27 (5):381-6. doi:
10.2500/ajra.2013.27.3934
Oyer S. L., Nagel W., Mulligan J. K.. Differential expression of adhesion molecules by sinonasal fibroblasts among control and chronic rhinosinusitis patients. American journal of rhinology and allergy 2013; 27 (5):381-386.
Oyer S. L., Smith V. A., Lentsch E. J.. Sex is not an independent risk factor for survival in differentiated thyroid cancer. Laryngoscope 2013; 123 (11):2913-2919. doi:
10.1002/lary.24018
Pachaiyappan B., Nowotarski S. L., Sokolosky M., Holshouser S. L., Sharma S. K., Casero R. A., Woster P. M.. Design, synthesis, and biological activities of novel oligoamines containing 3-5-3 linkers as epigenetic modulators. Abstracts of Papers of the American Chemical Society 2013; 246 ():#325-MEDI.
Pachaiyappan Boobalan, Nowotarski Shannon L., Sokolosky Melissa, Holshouser Steven L., Sharma Shiv K., Casero Robert A. Jr., Woster Patrick M.. Design, synthesis, and biological activities of novel oligoamines containing 3-5-3 linkers as epigenetic modulators. Abstracts of Papers, 246th ACS National Meeting and Exposition, Indianapolis, IN, United States, September 8-12, 2013 2013; ():MEDI-325.
Padula A. E., McGuier N. S., Griffin W. C., Lopez M. F., Becker H. C., Mulholland P. J.. Novel anticonvulsants for reducing alcohol consumption: a review of evidence from preclinical rodent drinking models. OA Alcohol 2013; 1 (1):8 pp. doi:
10.13172/2053-0285-1-1-446
Paintlia A. S., Paintlia M. K., Mohan S., Singh A. K., Singh I.. AMP-activated protein kinase signaling protects oligodendrocytes that restore central nervous system functions in an experimental autoimmune encephalomyelitis model. Am J Pathol 2013; 183 (2):526-41. doi:
10.1016/j.ajpath.2013.04.030
Paintlia A. S., Paintlia M. K., Singh A. K., Singh I.. Rho family GTPase inhibition protects immature oligodendrocytes against cytokine toxicity via PPAR-alfa dependent mechanism. Journal of Neurochemistry 2013; 125 ():206-206.
Paintlia A. S., Paintlia M. K., Singh A. K., Singh I.. Modulation of Rho-Rock signaling pathway protects oligodendrocytes against cytokine toxicity via PPAR-alpha-dependent mechanism. Glia 2013; 61 (9):1500-17. doi:
10.1002/glia.22537
Paintlia Ajaib S., Mohan Sarumathi, Singh Inderjit. Combinatorial effect of metformin and lovastatin impedes T-cell autoimmunity and neurodegeneration in experimental autoimmune encephalomyelitis. J. Clin. Cell. Immunol. 2013; 4 (3):1000149/1-1000149/10. doi:
10.4172/2155-9899.1000149
Paintlia M. K., Paintlia A. S., Singh A. K., Singh I.. S-Nitrosoglutathione Induces Ciliary Neurotrophic Factor Expression in Astrocytes, Which Has Implications to Protect the Central Nervous System under Pathological Conditions. Journal of Biological Chemistry 2013; 288 (6):3831-3843. doi:
10.1074/jbc.M112.405654
Paintlia Manjeet K., Paintlia Ajaib S., Singh Avtar K., Singh Inderjit. S-nitrosoglutathione induces ciliary neurotrophic factor expression in astrocytes, which has implications to protect the central nervous system under pathological conditions [Erratum]. Journal of Biological Chemistry 2013; 288 (16):11507. doi:
10.1074/jbc.A112.405654
Palesch S., Stoll D., Hebbar L.. Application of the Surgical Apgar Score as an Outcome Measure in Cadaveric Kidney Transplant Patients. Anesthesia and Analgesia 2013; 116 ():210-210.
Palesch Y. Y., Martin R. H., Hill M. D., Tamariz D., Jauch E. C., Weng Y., Speiser J. L., Woolson R. F., Barsan W. G., Moy C. S., Ginsberg M. D.. Meta-analysis of Albumin in Acute Stroke (ALIAS) Parts 1 and 2 Trials. Stroke 2013; 44 (12):E209-E209.
Palmer G. 2nd, Abernathy J. H. 3rd, Swinton G., Allison D., Greenstein J., Shappell S., Juang K., Reeves S. T.. Realizing improved patient care through human-centered operating room design: a human factors methodology for observing flow disruptions in the cardiothoracic operating room. Anesthesiology 2013; 119 (5):1066-77. doi:
10.1097/ALN.0b013e31829f68cf
Pandey J. P.. Immunoglobulin GM allotypes in multiple sclerosis. Annals of Neurology 2013; 73 (1):148. doi:
10.1002/ana.23804
Pandey J. P.. Immunoglobulin GM Allotypes as Effect Modifiers of Cytomegalovirus-Spurred Neuroblastoma. Cancer Epidemiol Biomarkers Prev 2013; 22 (11):1927-30. doi:
10.1158/1055-9965.epi-13-0612
Pandey J. P., Kistner-Griffin E., Namboodiri A. M., Black L., Jobim M.. Suggestive evidence that Fc variants of IgG2 and FcgammaRIIa loci interact to contribute to the risk of prostate cancer. Human Immunology 2013; 74 (12):1656-8. doi:
10.1016/j.humimm.2013.08.280
Pandey J. P., Li Z.. The forgotten tale of immunoglobulin allotypes in cancer risk and treatment. Exp Hematol Oncol 2013; 2 (1):6. doi:
10.1186/2162-3619-2-6
Pandey J. P., Namboodiri A. M., Kistner-Griffin E.. A genetic variant of Fc gamma RIIIa is strongly associatedwith humoral immunity to cyclin B1 in African American patients with prostate cancer. Immunogenetics 2013; 65 (2):91-96. doi:
10.1007/s00251-012-0660-y
Pandey J. P., Namboodiri A. M., Kistner-Griffin E.. IgG and Fc gamma R genotypes and humoral immunity to mucin 1 in prostate cancer. Human Immunology 2013; 74 (8):1030-1033. doi:
10.1016/j.humimm.2013.04.008
Pandey J. P., Namboodiri A. M., Kistner-Griffin E.. IgG and FcgammaR genotypes and humoral immunity to mucin 1 in prostate cancer. Human Immunology 2013; 74 (8):1030-3. doi:
10.1016/j.humimm.2013.04.008
Pandey J. P., Namboodiri A. M., Kistner-Griffin E., Iwasaki M., Kasuga Y., Hamada G. S., Tsugane S.. Racially restricted contribution of immunoglobulin Fcgamma and Fcgamma receptor genotypes to humoral immunity to human epidermal growth factor receptor 2 in breast cancer. Clinical and Experimental Immunology 2013; 171 (3):273-7. doi:
10.1111/cei.12018
Pandey J. P., Namboodiri A. M., Kistner-Griffin E., Iwasaki M., Kasuga Y., Hamada G. S., Tsugane S.. Racially restricted contribution of immunoglobulin Fcγ and Fcγ receptor genotypes to humoral immunity to human epidermal growth factor receptor 2 in breast cancer. Clin. Exp. Immunol. 2013; 171 (3):273-277. doi:
10.1111/cei.12018
Pandey J. P., Namboodiri A. M., Kistner-Griffin E., Iwasaki M., Kasuga Y., Hamada G. S., Tsugane S.. Racially restricted contribution of immunoglobulin Fcγ and Fcγ receptor genotypes to humoral immunity to human epidermal growth factor receptor 2 in breast cancer. Clin. Exp. Immunol. 2013; 171 (3):273-277. doi:
10.1111/cei.12018
Pandey Janardan P., Li Zihai. The forgotten tale of immunoglobulin allotypes in cancer risk and treatment. Exp. Hematol. Oncol. 2013; 2 ():6. doi:
10.1186/2162-3619-2-6
Pandey Janardan P., Li Zihai. The forgotten tale of immunoglobulin allotypes in cancer risk and treatment. Exp. Hematol. Oncol. 2013; 2 ():6. doi:
10.1186/2162-3619-2-6
